S. 1270 (119th)Bill Overview

Consensual Donation and Research Integrity Act of 2025

Health|Health
Cosponsors
Support
Bipartisan
Introduced
Apr 3, 2025
Discussions
Bill Text
Current stageCommittee

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
Plain-English summaryWhat this bill actually does

The bill creates a new federal registration and regulatory regime for persons who acquire and sell for profit whole human bodies or human body parts for education, research, or mortuary science (not for transplantation). It requires registration, inspections, recordkeeping (including donor consent documentation and chain-of-custody), labeling and packaging standards, limits on disclosure of identifiable donor information, disposition obligations, fees, and penalties for violations.

Why people may split

Federal registration and inspections versus state regulatory primacy

Watch point

Relative to its intended legislative type, this bill constitutes a clear substantive regulatory change that creates a framework for registration, recordkeeping, labeling, inspection, disposition, and enforcement for the interstate commercial acquisition and sale of whole human bodies and body parts not intended for transplantation.

The bill creates a new federal registration and regulatory regime for persons who acquire and sell for profit whole human bodies or human body parts for education, research, or mortuary science (not for transplantation).

It requires registration, inspections, recordkeeping (including donor consent documentation and chain-of-custody), labeling and packaging standards, limits on disclosure of identifiable donor information, disposition obligations, fees, and penalties for violations.

Certain entities are exempted, and the law applies two years after enactment.

Passage60/100

Narrow regulatory reform with limited ideological salience and built‑in compromise features increases plausibility; legal, privacy, and state‑law interactions create uncertainty.

CredibilityAligned

Relative to its intended legislative type, this bill constitutes a clear substantive regulatory change that creates a framework for registration, recordkeeping, labeling, inspection, disposition, and enforcement for the interstate commercial acquisition and sale of whole human bodies and body parts not intended for transplantation. It provides enumerated statutory requirements while delegating technical standards and operational details to executive regulation.

Contention55/100

Federal registration and inspections versus state regulatory primacy

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
Likely helpedLikely burdened

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • Potential benefitStrengthens donor consent and disposition protections with required documentation and return obligations.
  • Potential benefitImproves biosafety and reduces contamination risks through mandated labeling and packaging standards.
  • Potential benefitIncreases transparency via comprehensive recordkeeping and registrant identification for regulators and purchasers.
Likely burdened
  • Potential burdenImposes new compliance costs and recurring fees on commercial body and body-part sellers.
  • Potential burdenCould reduce availability of donated bodies for education and research due to added administrative burdens.
  • Potential burdenRequires labeling that may reveal donor identities or medical information, raising privacy concerns.
03 · Why people split

Why the argument around this bill splits.

Federal registration and inspections versus state regulatory primacy
Progressive85%

Likely broadly supportive because the bill strengthens donor consent, privacy, and respectful disposition requirements.

They would welcome chain-of-custody, labeling, and penalties for falsification but watch for enforcement strength and effects on research access.

Leans supportive
Centrist70%

Generally supportive of transparency, safety, and uniform standards across interstate commerce, while cautious about regulatory duplication and implementation costs.

Would seek clear rules on federal-state interaction and predictable fees and timelines.

Leans supportive
Conservative35%

Mixed reaction: supportive of protecting donors and criminalizing fraud, but skeptical of new federal registration, fee authority, and potential federal overreach into state-regulated mortuary practices.

Concerned about costs and regulatory burden on commerce.

Likely resistant
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood60/100

Narrow regulatory reform with limited ideological salience and built‑in compromise features increases plausibility; legal, privacy, and state‑law interactions create uncertainty.

Scope and complexity
52%
Scopemoderate
52%
Complexitymedium
Why this could stall
  • No cost estimate or CBO score included
  • Possible conflicts with HIPAA and state death‑disposition statutes
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Federal registration and inspections versus state regulatory primacy

Narrow regulatory reform with limited ideological salience and built‑in compromise features increases plausibility; legal, privacy, and sta…

Unlocked analysis

Relative to its intended legislative type, this bill constitutes a clear substantive regulatory change that creates a framework for registration, recordkeeping, labeling, inspection, disposition, and enforcement for the…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis